blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1809267

EP1809267 - PHARMACEUTICAL COMPOSITIONS BASED ON NK2 ANTAGONISTS FOR PEDIATRIC USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.12.2009
Database last updated on 20.09.2024
Most recent event   Tooltip11.10.2019Change - lapse in a contracting statepublished on 13.11.2019  [2019/46]
Applicant(s)For all designated states
Laboratori Guidotti S.P.A.
Loc. La Vettola, Via Livornese 897
56010 S. Piero a Grado PI / IT
[2007/30]
Inventor(s)01 / ALEOTTI, Alberto c/o LABORATORI GUIDOTTI S.P.A.
Via Livornese, 897 Loc. La Vettola
I-56010 S. PIERO A GRADO - PISA / IT
02 / ALTAMURA, Maria
Via S. Gervasio, 32
I-50131 FIRENZE / IT
03 / MAGGI, Carlo Alberto
Via L. Michelazzi, 43
I-50141 FIRENZE / IT
 [2007/30]
Representative(s)Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2009/40]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9
20122 Milano / IT
Former [2007/30]Gervasi, Gemma, et al
Notarbartolo & Gervasi S.p.A., Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date05810894.526.10.2005
[2007/30]
WO2005EP55575
Priority number, dateIT2004FI0022127.10.2004         Original published format: IT FI20040221
[2007/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006045820
Date:04.05.2006
Language:EN
[2006/18]
Type: A1 Application with search report 
No.:EP1809267
Date:25.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2006 takes the place of the publication of the European patent application.
[2007/30]
Type: B1 Patent specification 
No.:EP1809267
Date:18.02.2009
Language:EN
[2009/08]
Search report(s)International search report - published on:EP04.05.2006
ClassificationIPC:A61K31/00, A61K38/12, A61K31/451, A61K31/55, A61P1/06
[2007/30]
CPC:
A61K38/12 (EP,NO,US); A61K31/00 (EP,NO,US); A61K31/451 (EP,NO,US);
A61K31/55 (EP,NO,US); A61P1/00 (EP); A61P1/06 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/30]
Extension statesAL25.05.2007
BA25.05.2007
HR25.05.2007
MK25.05.2007
YU25.05.2007
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUF BASIS VON NK2-ANTAGONISTEN FÜR DEN PÄDIATRISCHEN GEBRAUCH[2007/30]
English:PHARMACEUTICAL COMPOSITIONS BASED ON NK2 ANTAGONISTS FOR PEDIATRIC USE[2007/30]
French:COMPOSITIONS PHARMACEUTIQUES A BASE D'ANTAGONISTES DE NK2 POUR USAGE PEDIATRIQUE[2007/30]
Entry into regional phase25.05.2007National basic fee paid 
25.05.2007Designation fee(s) paid 
25.05.2007Examination fee paid 
Examination procedure22.03.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.05.2007Amendment by applicant (claims and/or description)
25.05.2007Examination requested  [2007/30]
02.10.2007Despatch of a communication from the examining division (Time limit: M04)
17.01.2008Reply to a communication from the examining division
10.04.2008Despatch of a communication from the examining division (Time limit: M04)
19.05.2008Reply to a communication from the examining division
20.08.2008Communication of intention to grant the patent
15.12.2008Fee for grant paid
15.12.2008Fee for publishing/printing paid
Opposition(s)19.11.2009No opposition filed within time limit [2010/04]
Fees paidRenewal fee
08.10.2007Renewal fee patent year 03
22.09.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC31.10.2009
[2019/46]
Former [2011/32]MC31.10.2009
Former [2011/16]IT26.10.2009
MC31.10.2009
Former [2010/25]MC31.10.2009
Cited inInternational search[XY]WO9628467  (MENARINI FARMA IND [IT], et al) [X] 13,15-18 * claims 11-14 * * example 4 * [Y] 1-5,7,8,11,12,19,20;
 [DA]EP0815126  (MENARINI FARMA IND [IT]);
 [XDY]WO0129066  (MENARINI RICERCHE SPA [IT], et al) [XD] 1,2,5,11-13,15,17,18 * claims 11,12 * * page 5, lines 5-29 * * page 5, line 30 - page 6, line 6 * * examples 3,4 * [Y] 1-20;
 [DXY]WO03037916  (MENARINI RICERCHE SPA [IT], et al) [DX] 13,15-18 * examples 1,69,72,127,137 * * page 56, line 3; claims 11,12 * [Y] 1-5,11,12,14,19,20;
 [XY]WO2004037266  (NOVARTIS AG [CH], et al) [X] 13,15-18 * claim 6 * * page 8, columns 14-21 *[Y] 1-5,10-12,14,19,20;
 [XY]  - GIULIANI S ET AL, "EFFECT OF A TACHYKININ NK2 RECEPTOR ANTAGONIST, NEPADUTANT, ON CARDIOVASCULAR AND GASTROINTESTINAL FUNCTION IN RATS AND DOGS", EUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM, NL, (2001), vol. 415, ISSN 0014-2999, pages 61 - 71, XP002945503 [X] 1,7,8 * abstract * [Y] 1-20

DOI:   http://dx.doi.org/10.1016/S0014-2999(01)00794-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.